A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
BioCorRx Inc.
BICX
$5M
Mkt Cap
$0.25
+0.00%
BioCorRx Inc. (BICX) has a market capitalization of $5M. It is classified as a small-cap stock.
BioCorRx Inc. (BICX) does not currently pay a regular dividend.
BioCorRx Inc. (BICX) operates in the Services-Specialty Outpatient Facilities, Nec industry, within the Healthcare sector.
BioCorRx Inc. (BICX) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
BioCorRx Inc. (BICX) reported earnings per share (EPS) of $-0.19 in its most recent fiscal year.
BioCorRx Inc. (BICX) has a return on equity (ROE) of 29.5%. This indicates the company generates strong returns for shareholders.
The Ledger Terminal provides 16 years of financial data for BioCorRx Inc. (BICX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Corporate Structure We were incorporated as Cetrone Energy Company on January 28, 2008 in the State of Nevada. From inception until we completed our reverse acquisition of Fresh Start Private, Inc. (“FSP”), the principal business of the Company originally was to develop “green” renewable fuel sources for agricultural operations, specifically biodiesel. On July 26, 2010, we filed an amendment to our articles of incorporation changing our name to Fresh Start Private Management, Inc. During that time, we had no revenue and our operations were limited to capital formation, organization, and development of our business plan and target customer market. As a result of the reverse acquisition of FSP, on October 31, 2011, we ceased our prior operations and we are now a holding company and our wholly owned subsidiary engages in alcoholism and opioid addiction treatment through our BioCorRx® Recovery Program and related products.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | -3.4M | -3.4M | -5.1M | -3.8M | -4.4M | -5.2M |
| EPS | $-0.19 | $-0.19 | $-0.49 | $-0.43 | $-0.57 | $-0.81 |
| Free Cash Flow | -2.3M | -2.3M | -1.1M | -1.9M | -2.0M | -3.5M |
| ROIC | -177.8% | 0.0% | -1048.5% | -769.5% | -484.1% | -530.9% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | -0.12 | -0.14 | -0.14 | -0.08 | -0.11 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | -4.8M | -4.8M | -5.1M | -3.8M | -4.7M | -5.5M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | 0.0% | 29.5% | 46.5% | 42.1% | 58.2% | 93.3% |
| Shares Outstanding | 18M | 18M | 10M | 9M | 8M | 6M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | 451K | 152K | 1.1M | 4.3M | 1.6M | 1.5M | 891K | 1.5M | 1.8M | 1.8M |
| SG&A | 3.9M | 2.1M | 2.5M | 2.7M | 4.4M | 4.6M | 3.2M | 3.7M | 3.4M | 2.9M | 3.6M | 3.8M | 3.8M |
| EBIT | -3.1M | -5.1M | -2.2M | -2.9M | -4.6M | -5.6M | -7.5M | -5.5M | -4.7M | -3.8M | -5.1M | -4.8M | -4.8M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -3.1M | -4.7M | -5.9M | -30M | -6.6M | -6.0M | -3.5M | -5.2M | -4.4M | -3.8M | -5.1M | -3.4M | -3.4M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 250K | 2K | 0 | 141K | 0 | 48K | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -111.3% | N/M | N/M | N/M | N/M | -111.7% | N/M | N/M | N/M | N/M | N/M | 0.0% | -177.8% |
| ROE | -1021.1% | 313.5% | 103.5% | 494.1% | 137.2% | 178.8% | 133.1% | 93.3% | 58.2% | 42.1% | 46.5% | 29.5% | 0.0% |
| ROA | -73.5% | -170.0% | -629.5% | -7341.2% | -1361.6% | -265.2% | -121.7% | -393.7% | -551.7% | -652.0% | -1318.0% | -271.6% | -160.2% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 168K | 48K | -2.0M | -2.5M | -1.8M | -2.9M | -2.2M | -3.5M | -2.0M | -1.9M | -1.1M | -2.3M | -2.3M |
| Free Cash Flow | 167K | 48K | -2.3M | -2.5M | -1.8M | -3.1M | -2.2M | -3.5M | -2.0M | -1.9M | -1.1M | -2.3M | -2.3M |
| Owner Earnings | -268K | -531K | -2.6M | -3.4M | -4.6M | -4.9M | -2.6M | -3.8M | -2.4M | -2.2M | -2.3M | -2.9M | -2.9M |
| CapEx | 0 | 0 | 306K | 3K | 10K | 123K | 0 | 2K | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 135K | 125K | 15K | 21K | 7K | 35K | 64K | 64K | 27K | 27K | 33K | 44K | 44K |
| Growth CapEx | 0 | N/A | 291K | 0 | 3K | 88K | N/A | 0 | N/A | N/A | N/A | N/A | 0 |
| D&A | 135K | 125K | 15K | 21K | 7K | 35K | 64K | 64K | 27K | 27K | 33K | 44K | 44K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 300K | 454K | 582K | 831K | 2.8M | 2.0M | 355K | 210K | 355K | 277K | 1.2M | 593K | 593K |
| Debt Repayment | 96K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 1.9M | 2.2M | 6.2M | 2.6M | 497K | -2.3M | -7K | 702K | 545K | 1.3M | 1.7M | 1.3M | 1.3M |
| Cash & Equiv. | 53K | 220K | 142K | 11K | 280K | 2.6M | 592K | 86K | 69K | 65K | 88K | 139K | 139K |
| Long-Term Debt | 1.8M | 933K | 6.1M | 2.6M | 208K | 21K | 21K | 100K | 0 | 607K | 200K | 0 | N/A |
| Debt/Equity | 6.25 | -0.73 | -0.78 | -0.67 | -0.14 | -0.37 | -0.14 | -0.11 | -0.08 | -0.14 | -0.14 | -0.12 | 0.00 |
| Interest Coverage | -8.7 | -13.6 | -2.1 | -0.3 | -2.4 | -3.4 | -14.7 | -283.7 | -31.1 | -19.5 | -6.6 | -21.6 | -21.6 |
| Equity | 306K | -3.3M | -8.1M | -3.9M | -5.7M | -1.1M | -4.2M | -7.0M | -8.1M | -9.8M | -12M | -11M | -11M |
| Total Assets | 4.1M | 1.4M | 470K | 339K | 628K | 3.9M | 1.8M | 820K | 767K | 389K | 386K | 2.1M | 2.1M |
| Total Liabilities | 3.8M | 4.7M | 8.6M | 4.2M | 6.4M | 5.1M | 6.2M | 7.9M | 9.0M | 10M | 13M | 14M | 14M |
| Intangibles | 3.7M | 280K | N/A | 252K | N/A | 224K | 177K | 0 | 10K | 9K | 8K | 564K | 564K |
| Retained Earnings | -8.6M | -13M | -19M | -49M | -55M | -61M | -65M | -70M | -74M | -78M | -83M | -87M | -87M |
| Working Capital | -1.7M | -3.4M | -2.4M | -1.6M | -5.8M | 496K | -2.1M | -4.2M | -5.0M | -6.2M | -8.1M | -7.5M | -7.5M |
| Current Assets | 213K | 312K | 101K | 55K | 319K | 3.0M | 975K | 228K | 317K | 187K | 118K | 814K | 814K |
| Current Liabilities | 1.9M | 3.8M | 2.5M | 1.6M | 6.1M | 2.6M | 3.1M | 4.4M | 5.4M | 6.4M | 8.2M | 8.3M | 8.3M |
| Per Share Data | |||||||||||||
| EPS | -0.84 | -1.26 | -1.26 | -536.34 | -109.20 | -1.71 | -0.65 | -0.81 | -0.57 | -0.43 | -0.49 | -0.19 | -0.19 |
| Owner EPS | -0.07 | -0.14 | -0.55 | -61.24 | -76.96 | -1.40 | -0.48 | -0.59 | -0.31 | -0.25 | -0.23 | -0.16 | -0.16 |
| Book Value | 0.08 | -0.89 | -1.74 | -70.29 | -94.64 | -0.30 | -0.78 | -1.08 | -1.05 | -1.13 | -1.16 | -0.62 | -0.62 |
| Cash Flow/Share | 0.05 | 0.01 | -0.43 | -45.87 | -30.28 | -0.83 | -0.40 | -0.55 | -0.26 | -0.21 | -0.11 | -0.13 | -0.19 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 3.7M | 3.7M | 4.7M | 0.1M | 0.1M | 3.5M | 5.4M | 6.4M | 7.7M | 8.7M | 10.4M | 18.1M | 18.1M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | -31.5% | -33.5% | -10.5% | -22.1% | -14.4% | -17.9% | N/A | -50.8% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 9.7M | 6.4M | 34M | 9.3M | 13M | 6.1M | 0 | 4.5M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32 | 2.23 | 3.47 | 2.67 | 1.63 | 0.60 | 0.00 | 0.25 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.75 | 1.19 | 4.35 | 1.05 | 0.80 | 0.38 | 0.00 | 0.25 |
BioCorRx Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
BioCorRx Inc. (BICX) has a book value per share of $-0.62, based on its most recent annual SEC filing.
No recent press releases.